News

Understanding Recent Insider Trading Activity at Molina Healthcare

Understanding Recent Insider Trading Activity at Molina Healthcare

Overview of Recent Insider Trading at Molina Healthcare

In a noteworthy event, Richard M Schapiro, a Board Member at Molina Healthcare (NYSE:MOH), made headlines by selling a significant portion of his shares. This transaction has sparked interest among investors and market analysts alike, as insider trading activity often signals insights into company performance and future expectations.

Details of the Transaction

This recent insider selling saw Schapiro offload 357 shares of Molina Healthcare, valued at approximately $51,058, as per a Form 4 filing with the SEC. The sale occurred on November 24, illustrating a strategic decision by Schapiro in light of current market conditions.

Current Market Standing of Molina Healthcare

As of the latest trading session, Molina Healthcare's shares are priced at $144.75, which reflects a minor decline of 0.38%. This fluctuation in share price highlights the volatility often seen in the healthcare sector and the potential impact of insider transactions on investor sentiment.

Insights into Molina Healthcare's Business Model

Molina Healthcare Inc specializes in providing healthcare plans primarily focused on Medicaid support for low-income families and individuals. With its operation conducted through a network of subsidiaries, Molina functions under several segments including Medicaid, Medicare, and the Marketplace. The company predominantly generates revenue from the Medicaid segment, underscoring its commitment to government-supported healthcare programs.

Financial Performance Metrics

Revenue Growth: Recently, Molina Healthcare showcased an impressive revenue growth rate of 11.0% as of September 30, 2025. This growth is a positive indicator of the company's ability to expand its operations and increase its market share in a competitive environment.

  • Gross Margin: Molina Healthcare's gross margin currently stands at 8.08%, suggesting challenges in cost efficiency compared to industry peers.
  • Earnings Per Share (EPS): The company reports an EPS of 1.51, significantly surpassing the industry average, indicating solid profitability relative to its competitors.

Debt Management and Valuation Metrics

The debt-to-equity ratio for Molina Healthcare is recorded at 0.92, which is higher than the industry standard, reflecting a reliance on borrowed funds. This higher ratio can pose additional risks but also signifies the company’s strategy for growth through leveraging assets.

  • Price to Earnings (P/E) Ratio: At 8.95, Molina's P/E ratio is lower than the industry average, suggesting there may be opportunities for investment at a favorable valuation.
  • Price to Sales (P/S) Ratio: The stock’s P/S ratio of 0.18 indicates it might be undervalued relative to its sales, presenting potential buying opportunities for savvy investors.
  • EV/EBITDA Ratio: Molina’s EV/EBITDA ratio of 1.89 is also beneath the industry average, reinforcing that it may be undervalued.

The Importance of Insider Transactions

Understanding insider transactions is crucial for investors as they provide insights into the company's internal outlook. Insiders, including directors and officers, are mandated to report their trades, which often reflects their confidence in the company’s trajectory. Traditionally, insider purchases are seen as bullish indicators, while sales, although potentially viewed as bearish, can be motivated by various personal or financial reasons beyond mere stock performance.

Transaction Codes Explained

When analyzing insider transactions, investors focus on details outlined in Form 4 filings. A transaction labeled with a P indicates a purchase, whereas an S corresponds to a sale. Other codes, such as C for option conversions and A for grants, offer a fuller understanding of the insider's financial maneuvers.

Conclusion

Insider trading activity can provide astute insights that enhance an investor's perspective on company performance. For Molina Healthcare, the recent sale by Schapiro is one of many indicators that may shape future market perceptions and guidance.

Frequently Asked Questions

1. Who is Richard M Schapiro?

Richard M Schapiro is a Board Member at Molina Healthcare, involved in important company decisions and strategies.

2. What does Molina Healthcare specialize in?

Molina Healthcare focuses on providing healthcare plans primarily for Medicaid recipients, catering to low-income families and individuals.

3. What was the sales price of the shares sold by Schapiro?

Richard M Schapiro sold 357 shares of Molina Healthcare for approximately $51,058.

4. How has Molina Healthcare performed recently?

The company reported a revenue growth of 11.0% as of September 30, 2025, indicating strong operational performance.

5. What does the P/E ratio signify for Molina Healthcare?

Molina's P/E ratio of 8.95 suggests that its stock may be undervalued relative to earnings, potentially attracting investors looking for value opportunities.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Synova Global Taps Eventus for Top Trade Surveillance

Updated Category News Views 144

Synova and Eventus: A Powerful Partnership If you've ever traded a share or two, you know the name of the game is risk management. Step into Synova Global's latest move, and you'll see a gamble worth watching closely. This time around, Synova has tapped Eventus to bring their Validus trade surveillance platform into the fold. Now, Eventus and its star player, Validus,...

Continue Reading
Cambiotics Launches Key Trial on Reducing PFAS in Firefighters

Updated Category News Views 44

Pioneering Efforts to Combat 'Forever Chemicals' Cambiotics is stepping into some uncharted territory—tackling the tricky problem of PFAS accumulation in firefighters. If you’ve been following this, PFAS, or per- and polyfluoroalkyl substances, have been living rent-free in our bodies for years. Used in firefighting equipment and foams, these chemicals stick around,...

Continue Reading
ZBS Group Takes Over Rabinowitz’s CPA Practice with Bold Moves

Updated Category News Views 44

Transitioning Power in the CPA World Let's cut to the chase—when a seasoned CPA like Joseph Rabinowitz picks up the phone to secure a succession partner, it's a big deal. Enter ZBS Group LLP, steered by Michael Zaidman, which isn't a stranger to these waters, undertaking their fourth CPA practice acquisition through Rabinowitz's corner of the accounting universe....

Continue Reading
Connecting NIH Data: Transforming Scientific Discoveries

Updated Category News Views 44

Rethinking How Research Data Drives Discovery When researchers generate truckloads of data, finding patterns that lead to breakthroughs often becomes a game of hide and seek. It's like having a jumbo puzzle with pieces scattered all over the place. Enter the NIH Common Fund Data Ecosystem—a game changer attempting to glue together these pieces across the research...

Continue Reading
Cerbo's AI Scribe Expands to Telehealth Success

Updated Category News Views 46

Cerbo Enhances Telehealth With AI Scribe Expansion The digital healthcare playground looks like it's getting a nudge toward efficiency with Cerbo's latest move. Just when you thought telehealth couldn't get much sharper, these folks have drawn a line in the sand with their AI Scribe, which now makes its presence felt in virtual visits. No more juggling a dozen screens...

Continue Reading
SportsMed Expands to 58 Clinics, New Opening in Jersey City

Updated Category News Views 28

SportsMed Physical Therapy Expands with New Clinic Well, here we are, talking about expansion. And not just any expansion—I'm talking about SportsMed Physical Therapy flexing its muscles in Jersey City Heights, boosting their count to 58 clinics scattered across New Jersey and Connecticut. It's like watching a network of care roots spreading deeper into the region, and...

Continue Reading
Geopolitical Talks Shake Oil Market, Refine Stocks' Path

Updated Category News Views 92

Diplomacy Takes Center Stage So here we are again, riding the rollercoaster of geopolitics that's jerking the oil market around like a marionette. With the U.S. and Iran allegedly chatting—mind you, with a ton of smoke and mirrors through Qatar and Islamabad—every trader's watching, hoping for a ceasefire that might either stabilize or further jolt energy prices. Oil...

Continue Reading
Linker Vision's AI Platform Boosts Urban Planning

Updated Category News Views 72

Now, I've seen a fair share of tech rollouts claiming to change the world, but Linker Vision’s new AI platform, Linker AI Nexa, might actually be onto something real here. Revealed at the Smart City Expo World Congress 2026 in Barcelona, this isn't just another pretty interface—it’s packing some serious firepower with NVIDIA tech. Bringing Physical AI to City...

Continue Reading
Bright Minds Faces Legal Scrutiny Over FDA Trial Hold

Updated Category News Views 72

Bright Minds Biosciences Under the Microscope Well, it looks like Bright Minds Biosciences has found itself in some hot water with investors. After the FDA put a partial hold on their Phase 2 trial for BMB-101, designed for epilepsy treatment, the stock took a nosedive. If you're holding a piece of NASDAQ:DRUG, or even if you cut your losses and ran, it's time to tune in....

Continue Reading
Instanodes Tackling Quantum Threats in Blockchain

Updated Category News Views 114

Diving Into Quantum Cryptography for Blockchain Instanodes is throwing down the gauntlet for the blockchain crowd as the field of quantum computing edges ever closer to unsettling the cryptographic order. This company's latest play? Post-quantum account engineering for major players like Ethereum and Solana. And it's not just tinkering—they're giving the status quo a...

Continue Reading

Top 5 Most Recently Viewed Articles

MindMaze Therapeutics: 2026 Business Update and Insights

Updated Category News Views 16

Breaking Down MindMaze’s 2026 Update Today, I’m sifting through MindMaze Therapeutics' latest half-year report like a prospector panning for gold nuggets. It’s a mixed bag, folks, full of expansion optimism underlined by a nagging loss in the financial ledger. But they say fortune favors the bold, right? The company has ambitious ideas, and their genetic makeup...

Continue Reading
Tantrum Sportfishing Celebrates Record Blue Marlin Achievement

Updated Category News Views 190

Historic Milestone for Tantrum Sportfishing In an inspiring turn of events for the sportfishing community, Tantrum Sportfishing has achieved a remarkable milestone. The Kona-based charter company announced its proud entry into the illustrious "Grander Club" after landing a colossal 1,039-pound Blue Marlin. This catch not only signifies a personal triumph for the team but...

Continue Reading
New Bitcoin ETF Offers Investors Unique Downside Protection

Updated Category News Views 227

Calamos Introduces a Groundbreaking Bitcoin ETF Investment management firm Calamos is excited to roll out an innovative approach to cryptocurrency investing with the launch of the world’s first 100% downside-protected Bitcoin exchange-traded fund (ETF). This launch comes just after an announcement suggesting that an ETF will be available for investors looking to...

Continue Reading
Exciting Developments in dsm-firmenich's Share Repurchase Initiative

Updated Category News Views 178

Progress Update on dsm-firmenich's Share Repurchase Program dsm-firmenich, known for its innovative approach in the fields of nutrition, health, and beauty, is actively implementing its large-scale share repurchase program. This initiative began earlier this year and signifies a strategic move to enhance shareholder value and manage capital effectively. Initial...

Continue Reading
Capricor Therapeutics: Key Deadlines for Shareholders to Remember

Updated Category News Views 133

Crucial Dates for Capricor Therapeutics Shareholders The Gross Law Firm has released an important notice for shareholders of Capricor Therapeutics, Inc. (NASDAQ: CAPR). The firm encourages anyone who purchased shares during the specified class period to connect with them regarding possible lead plaintiff appointments. Being appointed as the lead plaintiff isn't necessary...

Continue Reading